Skip to content

1-2-3 Magic treatment for families with children with attention deficit hyperactivity disorder (ADHD)

A randomised wait-list controlled trial evaluating 1-2-3 Magic and its effectiveness on families with children with ADHD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15281572
Enrollment
100
Registered
2021-12-06
Start date
2021-12-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioural parenting programme for parents with children with ADHD Mental and Behavioural Disorders Disturbance of activity and attention

Interventions

To test the effectiveness of the 1-2-3 Magic Programme administered online via Zoom, a randomised waiting-list controlled trial has been designed to evaluate whether 1-2-3 Magic can reduce parents’ pe

Sponsors

University College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 25/07/2023: 1. Parents of children aged 12 years old and under 2. Parents of children with an official diagnosis of ADHD 3. Parents who speak, read, and write proficient English Previous participant inclusion criteria: 1. Parents of children under the age of 12 years 2. Parents of children with an official diagnosis of ADHD 3. Parents who speak, read, and write proficient English

Exclusion criteria

Exclusion criteria: Individual cannot read, write or speak proficient English

Design outcomes

Primary

MeasureTime frame
Parent self-efficacy measured through Tool to Measure Parenting Self-Efficacy (TOPSE) will be measured at the baseline session, before the first session (for arms 2 and 3), the last session of the programme and 6 months follow-up

Secondary

MeasureTime frame
Child disruptive behaviour through Eyberg Child Behaviour Inventory (ECBI) will be measured at the baseline session, before the first session (for arms 2 and 3), the last session of the programme and 6 months follow-up

Countries

England, United Kingdom

Contacts

Public ContactKirstie Wong
kirstie.wong.20@ucl.ac.uk+44 (0)7476975797

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026